Evidence map›Paper›PMID 7869048›Full record

ArticleThe Journal of experimental medicine1995

Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells.

L G Baum, M Pang, N L Perillo, T Wu, A Delegeane, C H Uittenbogaart, M Fukuda, J J Seilhamer

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 254 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Thymic Microenvironment Is Modified by Malnutrition andFrontiers in cellular and infection microbiology · 2019
    Article
  6. Galectin-1 Influences Breast Cancer Cell Adhesion to E-selectinCellular and molecular bioengineering · 2018
    Article
  7. Article
  8. Article
  9. Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
  10. Evolving mechanistic insights into galectin functions.Methods in molecular biology (Clifton, N.J.) · 2015
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Mucin O-glycan branching enzymes: structure, function, and gene regulation.Advances in experimental medicine and biology · 2011
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

L G BaumDepartment of Pathology and Laboratory Medicine, UCLA School of Medicine 90024.
M Pang
N L Perillo
T Wu
A Delegeane
C H Uittenbogaart
M Fukuda
J J Seilhamer
UCLA Health · US

Funding

GLYCOPROTEINS IN NORMAL &LEUKEMIC CELL DIFFERENTIATIONR01CA033895 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1985 to 2010
$3.7M
GLYCOPROTEINS IN DIFFERENTIATION AND ONCOGENESISR37CA033000 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI FUKUDA, MINORU · 1995 to 2004
$2.1M
GLYCOPROTEINS IN DIFFERENTIATION AND ONCOGENESISR01CA033000 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1985 to 2009
$1.8M
NCI NIH HHS CA-33000NCI NIH HHS CA-33895NIAID NIH HHS AI-07126
6 · The paper itself

Abstract

Thymic epithelial cells play a crucial role in the selection of developing thymocytes. Thymocyte-epithelial cell interactions involve a number of adhesion molecules, including members of the integrin and immunoglobulin superfamilies. We found that human thymic epithelial cells synthesize an endogenous lectin, galectin-1, which binds to oligosaccharide ligands on the surface of thymocytes and T lymphoblastoid cells. Binding of T lymphoblastoid cells to thymic epithelial cells was inhibited by antibody to galectin-1 on the epithelial cells, and by two antibodies, T305 and 2B11, that recognize carbohydrate epitopes on the T cell surface glycoproteins CD43 and CD45, respectively. T lymphoblastoid cells and thymocytes bound recombinant galectin-1, as demonstrated by flow cytometric analysis, and lectin binding was completely inhibited in the presence of lactose. The degree of galectin-1 binding to thymocytes correlated with the maturation stage of the cells, as immature thymocytes bound more galectin-1 than did mature thymocytes. Preferential binding of galectin-1 to immature thymocytes may result from regulated expression of preferred oligosaccharide ligands on those cells, since we found that the epitope recognized by the T305 antibody, the core 2 O-glycan structure on CD43, was expressed on cortical, but not medullary cells. The level of expression of the UDP-GlcNAc:Gal beta 1,3GalNAc-R beta 1, 6GlcNAc transferase (core 2 beta 1, 6 GlcNAc transferase, or C2GnT), which creates the core 2 O-glycan structure, correlated with the glycosylation change between cortical and medullary cells. Expression of mRNA encoding the C2GnT was high in subcapsular and cortical thymocytes and low in medullary thymocytes, as demonstrated by in situ hybridization. These results suggest that galectin-1 participates in thymocyte-thymic epithelial cell interactions, and that this interaction may be regulated by expression of relevant oligosaccharide ligands on the thymocyte cell surface.

Indexed as

Antigens, CDAnimalsCD3 ComplexCell CommunicationChildEpitheliumGalectin 1HemagglutininsHumansInfantLectinsLeukocyte Common AntigensLeukosialinMicePolysaccharidesRabbitsAntigens, CDCD3 ComplexGalectin 1HemagglutininsLectinsLeukocyte Common AntigensLeukosialinPolysaccharidesSialoglycoproteinsSPN protein, humanSpn protein, mouse

Identifiers

PMID7869048
PMCPMC2191916
OpenAlexW2171872740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.